B. Matthews

发表

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Sterling C. Johnson, David T. Jones, Nick C Fox, 2019, Scientific Reports.

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Alan C. Evans, Sterling C. Johnson, Keith A. Johnson, 2019, bioRxiv.

Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer disease.

E. Siemers, B. Matthews, P. Mozley, 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

On the path to 2025: understanding the Alzheimer’s disease continuum

Roy W Jones, J. Morris, C. Jack, 2017, Alzheimer's Research & Therapy.

Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex.

B. Miller, M. Gorno-Tempini, W. Seeley, 2008, Brain : a journal of neurology.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Nick C Fox, 2016, Scientific Reports.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Norbert Schuff, Robert C. Green, Andrew J. Saykin, 2017 .

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Nature Communications.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2020, Scientific Reports.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2019, Nature Communications.

18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

David T. Jones, Keith A. Johnson, Jeffrey N. Browndyke, 2018, Anesthesiology.

Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review

B. Matthews, U. Reuter, L. S. Loo, 2020, Advances in Therapy.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

Accuracy of Florbetapir PET Imaging in Alzheimer Disease

B. Matthews, 2012 .

THE PATIENT VOICE: EXPLORING TREATMENT PREFERENCES IN PARTICIPANTS WITH MILD COGNITIVE CONCERNS TO INFORM REGULATORY DECISION MAKING

E. Siemers, A. Hauber, C. Mansfield, 2017, Alzheimer's & Dementia.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Using Meta-Analyses to Better Understand Amyloid Imaging Implications

B. Matthews, 2015 .

Mild Cognitive Impairment Due to Alzheimer Disease: Diagnostic Criteria Compared

B. Matthews, 2015 .

Faculty Opinions recommendation of Regional patterns of brain tissue loss associated with depression in Parkinson disease.

B. Matthews, 2010 .

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

Depression and Cognitive Impairment in Older Adults

B. Matthews, 2013 .

Investigational Alzheimer Drugs Fail to Improve Cognition or Function in Phase III Trials

B. Matthews, 2014 .

Alzheimer Disease Risk Variant Discovered

B. Matthews, 2012 .

Clusterin and Alzheimer Disease

B. Matthews, 2011 .

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

A. Hake, J. Krege, B. Matthews, 2020, Neurology and Therapy.

Depressive symptoms in Chinese-American subjects with cognitive impairment.

J. Kramer, K. Yaffe, J. Yokoyama, 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair.

T. Tihan, B. Matthews, R. Ramachandran, 2008, Archives of pathology & laboratory medicine.

Clinicopathological correlations in behavioural variant frontotemporal dementia

Jesse A. Brown, D. Geschwind, K. Vossel, 2017, Brain : a journal of neurology.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

Sterling C. Johnson, Nick C Fox, John X. Morris, 2020, Brain communications.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2016, Scientific Reports.

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keith A. Johnson, Joanne L. Lord, Colleen S. Albers, 2016, Molecular Neurobiology.

ALZHEIMER DISEASE UPDATE

B. Matthews, 2010, Continuum.

The musical brain.

B. Matthews, 2008, Handbook of clinical neurology.

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

B. Matthews, D. Ball, U. Desai, 2019, Alzheimer's & dementia.

Young-Onset Dementia

B. Matthews, Brandy R Matthews, Dulanji K Kuruppu, 2013, Seminars in Neurology.

Pleasurable emotional response to music: A case of neurodegenerative generalized auditory agnosia

Chiung-Chih Chang, J. Engstrom, Chiung-Chih Chang, 2009, Neurocase.

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Keith A. Johnson, Scott Ayton, Joanne L. Lord, 2015, Nature Communications.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Keith A. Johnson, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Cerebrospinal Fluid Proteins in Creutzfeldt-Jakob Disease

B. Matthews, 2012 .

Cerebellar ataxia and central nervous system whipple disease.

Lyell K. Jones, B. Matthews, K. Josephs, 2005, Archives of neurology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia

K. Rankin, M. Gorno-Tempini, W. Seeley, 2007, Neurology.

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

P. Tariot, B. Vellas, J. Schumi, 2019, JAMA neurology.

Frontotemporal Lobar Degeneration

B. Matthews, Rachel Seltman, 2012, CNS Drugs.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2018, Molecular Neurobiology.

Updated Diagnostic Criteria for All Stages of Alzheimer Disease

B. Matthews, 2011 .

Memory Dysfunction

B. Matthews, 2015, Continuum.

Apolipoprotein ε4 Is Associated with Lower Brain Volume in Cognitively Normal Chinese but Not White Older Adults

Michael W. Weiner, Owen T. Carmichael, Howard J. Rosen, 2015, PloS one.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

Implementing innovative models of dementia care: The Healthy Aging Brain Center

Cathy C Schubert, Malaz A Boustani, Stephanie Munger, 2011, Aging & mental health.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014

B. Matthews, U. Desai, P. Zuckerman, 2019, Journal of the American Geriatrics Society.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Faculty Opinions recommendation of Vitamin D deficiency predicts cognitive decline in older men and women: The Pro.V.A. Study.

Matthew S. Gentry, B. Matthews, 2015 .

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)

B. Matthews, Joshua Scott Andrews, U. Desai, 2023, Alzheimer's & Dementia : Translational Research & Clinical Interventions.

Expectations and clinical meaningfulness of randomized controlled trials

Christopher J. Weber, R. Petersen, M. Carrillo, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Recruitment of Chinese American elders into dementia research: the UCSF ADRC experience.

H. Rosen, B. Matthews, Marian M Tse, 2011, The Gerontologist.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

Frontotemporal Dementia Caregivers and Researchers

Sujuan Gao, S. Gao, B. Matthews, 2011, American journal of Alzheimer's disease and other dementias.

Reply: A few comments on Ravel's diseases

W. Seeley, B. Matthews, B. Miller, 2008 .

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

Abdominal mesothelioma in a dog.

B. Matthews, D. C. Forbes, 1991, The Canadian veterinary journal = La revue veterinaire canadienne.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

Frontotemporal dementia in eight Chinese individuals

W. Seeley, H. Rosen, B. Matthews, 2013, Neurocase.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Keith A. Johnson, Michael W. Paul Ronald Clifford R. Andrew J. William John Weiner Aisen Petersen Jack Saykin Jagust , Sherye A. Sirrel, 2019, Scientific Reports.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

The Behavioral Neurology of Dementia: Alzheimer's disease

B. Matthews, B. Miller, 2009 .

Depressive symptoms in Chinese Americans with Cognitive Impairment.

J. Kramer, K. Yaffe, J. Yokoyama, 2014 .

Preclinical Alzheimer Disease Prevalence and Outcomes

B. Matthews, 2013 .

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Sherye A. Sirrel, 2020, Scientific Reports.

The Growing Burden of Dementia in China

B. Matthews, 2013 .

Tetanus in a dog.

B. Matthews, D. C. Forbes, 1985, The Canadian veterinary journal = La revue veterinaire canadienne.

Bravo! Neurology at the opera.

B. Matthews, 2010, Frontiers of neurology and neuroscience.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Non-coding variability at the APOE locus contributes to the Alzheimerâ€TMs risk

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019 .

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making

C. Mansfield, B. Matthews, A. Tockhorn-Heidenreich, 2022, The Patient - Patient-Centered Outcomes Research.

Past Infections Are Tied to Cognitive Impairment

B. Matthews, 2013 .

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Sterling C. Johnson, Sherye A. Sirrel, Alice D. Brown, 2015, Nature Communications.

Journal Club: Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology

B. Matthews, J. Brosch, 2014, Neurology.

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Sterling C. Johnson, David T. Jones, Nick C Fox, 2017, Scientific Reports.

Late-Onset Alzheimer Disease Susceptibility Genes in Black Americans

B. Matthews, 2013 .